Stealth BioTherapeutics Corp. ADS
MITO
MITO was delisted on the 15th of November, 2022.
14 hedge funds and large institutions have $987K invested in Stealth BioTherapeutics Corp. ADS in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
17% more funds holding
Funds holding: 12 → 14 (+2)
22% less capital invested
Capital invested by funds: $1.26M → $987K (-$271K)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$48.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$33.2K |
| 3 |
Two Sigma Advisers
New York
|
+$3.66K |
| 4 |
HF
HRT Financial
New York
|
+$3.21K |
| 5 |
AA
AlphaMark Advisors
Ft. Wright,
Kentucky
|
+$3.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$138K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$20.1K |
| 3 |
Renaissance Technologies
New York
|
-$20.1K |
| 4 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$18.7K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$12.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IC
1
Ikarian Capital
Dallas,
Texas
| $651K | -$12.8K | -9,453 | -2% |
|
|
2
Renaissance Technologies
New York
| $91K | -$20.1K | -14,800 | -18% |
|
|
BFM
3
Boothbay Fund Management
New York
| $66K | -$12.8K | -9,453 | -16% |
|
|
4
Millennium Management
New York
| $49K | +$48.7K | +35,903 | New |
|
|
5
Two Sigma Advisers
New York
| $35K | +$3.66K | +2,700 | +12% |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $33K | +$33.2K | +24,502 | New |
|
|
HF
7
HRT Financial
New York
| $26K | +$3.21K | +2,368 | +14% |
|
|
SBL
8
Sargent Bickham Lagudis
Boulder,
Colorado
| $20K | – | – | – |
|
9
Morgan Stanley
New York
| $8K | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $4K | +$643 | +474 | +21% |
|
|
AA
11
AlphaMark Advisors
Ft. Wright,
Kentucky
| $3K | +$3.13K | +2,306 | New |
|
|
12
UBS Group
Zurich,
Switzerland
| $1K | -$20.1K | -14,820 | -97% |
|
|
BBHC
13
Brown Brothers Harriman & Co
New York
| $238 | – | – | – |
|
|
14
Goldman Sachs
New York
| – | -$138K | -88,426 | Closed |
|
|
PAM
15
PVG Asset Management
Golden,
Colorado
| – | -$18.7K | -11,988 | Closed |
|
|
TRCT
16
Tower Research Capital (TRC)
New York
| – | +$91 | +67 | New |
|
MITO Hedge Fund Activity: Q3 2021 in Review
14 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q3 2021, worth a combined $987K — down 22% from $1.26M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new MITO positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $48.7K. The largest seller was Goldman Sachs, exiting entirely with an estimated $138K sold.
- 14 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q3 2021, up from 12 in Q2 2021.
- Funds reported $987K of Stealth BioTherapeutics Corp. ADS stock for Q3 2021, down 22% quarter-over-quarter.
- 4 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q3 2021 and 2 closed out, a net change of +2 holders.
- The largest Stealth BioTherapeutics Corp. ADS buyer in Q3 2021 was Millennium Management, an estimated $48.7K added.
- The largest Stealth BioTherapeutics Corp. ADS seller in Q3 2021 was Goldman Sachs, an estimated $138K sold.
Based on aggregated 13F filings for Q3 2021.